1 study found for:    23077849 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: DTacP-IPV combined vaccine (TETRAXIM™)

Indicates status has not been verified in more than two years